Aquagest Injection 1.119Ml

Aquagest Injection 1.119Ml may interact with other medicines, such as:

• Antidiabetic medicines (e.g., insulin, metformin): Hormonal therapy may alter blood sugar control in some individuals. Blood glucose monitoring may be required.
• Antitubercular medicines (e.g., rifampicin): These medicines may reduce progesterone levels by increasing its metabolism, which may affect treatment response.
• Antiepileptic medicines (e.g., phenytoin, carbamazepine, phenobarbital): These medicines may increase the breakdown of progesterone in the body and reduce its effectiveness.
• Other hormonal medicines (e.g., estrogen-containing hormone therapy): Combined use may increase the risk of hormonal side effects such as fluid retention, breast tenderness, or blood clot-related complications.
• Corticosteroids (e.g., prednisolone): Progesterone may affect the metabolism of corticosteroids and alter their effects in some patients.

Use Aquagest Injection 1.119Ml with caution if you have:

• Mood disorders: Hormonal therapy may worsen mood changes, irritability, or other related symptoms in susceptible individuals. Patients with a history of psychiatric conditions may require monitoring during treatment.
• Epilepsy or seizure disorders: Hormonal changes associated with progesterone therapy may affect seizure threshold in some patients. Caution is advised in individuals with epilepsy or a seizure history.
• Diabetes: Hormonal therapy may affect glucose metabolism in some individuals and may alter blood sugar control. Patients with diabetes may require regular blood glucose monitoring during treatment.
• History of blood clots (e.g., deep vein thrombosis, pulmonary embolism, stroke): Hormonal medicines may increase the risk of thromboembolic complications in susceptible individuals. Patients with a previous history of clotting disorders should use this medicine only under close medical supervision.

The dose and duration of treatment will be decided by your doctor based on your condition and response to treatment. Follow the prescribed treatment schedule carefully and attend all follow-up appointments recommended by your doctor.

Receiving more than the prescribed amount of Aquagest Injection 1.119Ml may increase the risk of side effects such as excessive drowsiness, dizziness, nausea, mood changes, or hormonal disturbances. Seek immediate medical attention if overdose is suspected or if unusual symptoms develop after administration.

If you miss a scheduled appointment for Aquagest Injection 1.119Ml, contact your doctor or healthcare provider as soon as possible to reschedule it. Do not attempt to self-administer or take additional medicine to make up for the missed dose unless advised by your doctor.